SKI Market

A+| A| A-|

Indian Indices

Sensex

75,200.85 -114.19
( -0.15%)

Global Indices

Nasdaq

49,708.56 161.38
(0.33%)

Dow Jones

7,424.10 -5.40
(-0.07%)

Hang Seng

60,409.17 -406.78
(-0.67%)

Nikkei 225

10,297.25 101.88
(1.00%)

Forex

USD-INR

95.89 0.18
(0.19%)

EUR-INR

111.46 -0.47
(-0.42%)

GBP-INR

127.74 -1.27
(-0.99%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Alivus Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543322

INE03Q201024

271.4805949

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALIVUS

22.2

12958.22

EPS(TTM)

Face Value()

Div & Yield %

47.56

0.47

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	2386.88	2283.21	2161.22	2123.21	1885.17	1537.31
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2386.88	2283.21	2161.22	2123.21	1885.17	1537.31
Other Income	34.57	12.04	28.96	14.70	0.81	11.99
Stock Adjustments	-27.35	56.57	84.44	-41.32	70.70	4.64
Total Income	2394.10	2351.82	2274.62	2096.59	1956.68	1553.94
EXPENDITURE :
Raw Materials	1010.09	1025.21	1068.56	977.96	948.17	668.66
Power & Fuel Cost	117.24	112.46	115.60	100.92	74.19	76.75
Employee Cost	251.70	258.16	180.18	168.72	149.13	142.28
Other Manufacturing Expenses	177.41	163.64	137.17	124.04	107.32	108.04
Selling & Administrative Expenses	83.58	64.12	65.47	48.19	48.50	42.05
Miscellaneous Expenses	36.93	41.97	36.39	46.01	37.49	32.22
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1676.95	1665.54	1603.36	1465.83	1364.80	1069.99
Operating Profit	717.15	686.29	671.25	630.76	591.89	483.96
Interest	2.41	1.55	0.55	27.96	87.55	33.52
Gross Profit	714.74	684.74	670.70	602.80	504.34	450.44
Depreciation	60.61	53.45	42.09	37.88	33.39	29.37
Profit Before Tax	654.13	631.29	628.61	564.92	470.95	421.07
Tax	162.44	152.21	150.61	137.63	112.75	98.54
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	6.06	8.19	11.04	8.57	6.62	9.43
Reported Net Profit	485.63	470.89	466.96	418.72	351.58	313.10
Extraordinary Items	4.30	-0.53	-0.41	-0.55	-0.44	-0.91
Adjusted Net Profit	481.33	471.42	467.37	419.27	352.02	314.01
Adjustment below Net Profit	-0.25	-5.46	-0.29	-19.50	-0.53	0.47
P & L Balance brought forward	1291.80	1102.06	1021.35	750.79	399.73	86.17
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	275.69	385.96	128.65	0.00	0.00
P & L Balance carried down	1777.18	1291.80	1102.06	1021.35	750.79	399.73
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	250.00	1125.00	2100.00	1050.00	0.00	0.00
Dividend Per Share(Rs)	5.00	22.50	42.00	21.00	0.00	0.00
Earnings Per Share-Unit Curr	39.63	38.43	38.11	34.17	358.76	1597.44
Earnings Per Share(Adj)-Unit Curr	39.63	38.43	38.11	34.17	358.76	1597.44
Book Value-Unit Curr	229.92	190.35	174.51	167.66	768.11	2049.45
Book Value(Adj)-Unit Curr	229.92	190.35	174.51	167.66	768.11	2049.45

75,200.85 -114.19 ( -0.15%)

49,708.56 161.38 (0.33%)

7,424.10 -5.40 (-0.07%)

60,409.17 -406.78 (-0.67%)

10,297.25 101.88 (1.00%)

95.89 0.18 (0.19%)

111.46 -0.47 (-0.42%)

127.74 -1.27 (-0.99%)

0.60 0.00 (-0.28%)